Related Experiment Videos
Cytokines, stress, and depressive illness
1Institute of Neuroscience, Carleton University, Ottowa, Ont, Canada K1S 5B6. hanisman@ccs.carleton.ca
Brain, Behavior, and Immunity
|October 29, 2002
Summary
Elevated cytokines, such as interleukin-6, may be linked to depression. These immune markers might indicate a predisposition to depression, even after treatment, suggesting a complex relationship.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Depression is associated with immune system activation, including elevated cytokines like interleukin-1, interleukin-2, interleukin-6, and tumor necrosis factor-alpha.
- The role of these cytokines in depression is complex, potentially acting as trait markers or bystander effects.
Purpose of the Study:
- To explore the relationship between cytokine activity and depression.
- To investigate whether cytokines are trait markers or merely associated with the illness.
Main Methods:
- Correlational studies analyzing cytokine levels in depressive populations.
- Observational data from patients receiving cytokine immunotherapy and their depressive symptoms.
Main Results:
- Cytokine elevations are most prominent in severe melancholic depression and may correlate with chronicity and neurovegetative symptoms.
- Patients undergoing cytokine immunotherapy often develop depressive symptoms, which can be alleviated by antidepressants, suggesting a potential causal link.
Conclusions:
- Cytokines may play a causal role in depressive disorders.
- The affective changes associated with cytokines might arise from neuroendocrine and neurochemical alterations.
- Further research is needed to elucidate the precise mechanisms underlying the link between cytokines and depression.